BMS and J&J's Librexia AF study is also comparing milvexian to Eliquis to see if it can prevent stroke and other clotting ...
Discover why Cytokinetics (CYTK) is a top BUY in precision cardiology. Learn about aficamten, its market potential, and ...
Shares in Sarepta reversed some of their recent declines after the FDA added a warning label to its Duchenne muscular ...
Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage biopharmaceutical company ...
This survey brief examines factors contributing to burnout among primary care physicians in 10 countries and strategies to ...
Researchers discovered that chronic inflammation fundamentally remodels the bone marrow, allowing mutated stem cell clones to ...
Ryan Haumschild, PharmD, MS, MBA, introduces the faculty and sets the agenda to explore disease background, novel therapies, ...
As the federal government dismantles the country’s vaccine infrastructure, the burden of ensuring access to vaccines for flu, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback